The density of GABA A receptors (GABA A Rs) at synapses regulates brain excitability, and altered inhibition may contribute to Huntington's disease, which is caused by a polyglutamine repeat in the protein huntingtin. However, the machinery that delivers GABA A Rs to synapses is unknown. We demonstrate that GABA A Rs are trafficked to synapses by the kinesin family motor protein 5 (KIF5). We identify the adaptor linking the receptors to KIF5 as the huntingtin-associated protein 1 (HAP1). Disrupting the HAP1-KIF5 complex decreases synaptic GABA A R number and reduces the amplitude of inhibitory postsynaptic currents. When huntingtin is mutated, as in Huntington's disease, GABA A R transport and inhibitory synaptic currents are reduced. Thus, HAP1-KIF5-dependent GABA A R trafficking is a fundamental mechanism controlling the strength of synaptic inhibition in the brain. Its disruption by mutant huntingtin may explain some of the defects in brain information processing occurring in Huntington's disease and provides a molecular target for therapeutic approaches.
INTRODUCTION
Synaptic inhibition plays a critical role in regulating neuronal excitability and information processing in the brain. The number of GABA A Rs expressed in the surface membrane and at synaptic sites is a critical determinant of inhibitory synapse strength (Arancibia-Carcamo and Jacob et al., 2008) , but the molecular machinery that deliver GABA A Rs to synapses remain unclear. Importantly, the role of kinesin family (KIF) microtubule motors in regulating the strength and plasticity of GABAergic transmission is unknown, as is the identity of the adaptor molecules which link GABA A Rs to their trafficking motors.
Alterations in protein trafficking to neuronal membranes, including altered trafficking of GABA A Rs, occur in a number of neurological and psychiatric diseases (Jacob et al., 2008; Olkkonen and Ikonen, 2006) . Altered GABA A R trafficking may underlie or exacerbate disease progression by altering the excitatory/inhibitory balance, leading to neuronal excitotoxicity and/or disrupted information processing (Arancibia-Carcamo and Jacob et al., 2008) . In Huntington's disease (HD), a polyglutamine expansion in the huntingtin protein (polyQ-htt) results in cell death and neurodegeneration of specific neuronal populations, leading to uncontrolled movements, personality changes, dementia, and eventually death within 10-20 years of the first symptoms. In addition to roles in regulating apoptosis and transcription, huntingtin may have a neurotoxic role in HD by altering intracellular transport of proteins, including transport of NMDA receptors Gunawardena et al., 2003; Smith et al., 2005; Szebenyi et al., 2003; Gauthier et al., 2004) . Whether mutant huntingtin disrupts GABA A R trafficking, leading to compromised inhibition and disruption of the excitatory/inhibitory balance, remains unknown.
A key mediator of pathological alterations in protein trafficking produced by polyQ-htt is the huntingtin-associated protein 1 (HAP1; (Gauthier et al., 2004; Li and Li, 2005; Li et al., 1995) . HAP1 interacts directly with GABA A Rs and facilitates their recycling back to synapses after they have been internalized from the surface membrane, and so can regulate the strength of inhibitory synaptic transmission (Kittler et al., 2004) , but how HAP1 regulates GABA A R trafficking to synapses and whether this trafficking is a target for mutant polyQ-htt remains unknown.
Here, using biochemical, imaging, and electrophysiological approaches, we show that HAP1 is an adaptor that links GABA A Rs to KIF5 motors, forming a motor protein complex for rapid delivery of GABA A Rs to synapses. Furthermore, mutant huntingtin containing a polyQ expansion that disrupts HAP1 function (Gauthier et al., 2004; Li et al., 1995) inhibits this KIF5-dependent GABA A R trafficking and synaptic delivery. Thus, KIF5-dependent transport is critical for delivery of GABA A Rs to inhibitory synapses, and disruption of this complex by mutant huntingtin may lead to altered synaptic inhibition and increased neuronal excitability in Huntington's disease.
RESULTS
The Delivery of GABA A Rs to Synapses Is Mediated by the Motor KIF5 The kinesin motor protein KIF5 is a critical determinant of intracellular transport processes in neurons (Hirokawa and Takemura, 2005) . To investigate if KIF5 activity is important for inhibitory transmission, we carried out whole-cell patch-clamp recordings to measure inhibitory synaptic transmission in cortical neurons dialyzed via the electrophysiological recording pipette with an antibody demonstrated to block KIF5 motor protein activity (kinesin function blocking antibody SUK4 [Ingold et al., 1988; Jaulin et al., 2007] ), which does not inhibit myosin-or dynein-based motility (Bi et al., 1997; Lane and Allan, 1999) . This was compared with neurons dialyzed with a control antibody (9E10) that does not recognize KIF5. Dialysis of SUK4 (Figures 1A , 1C, and 1F) caused a rapid reduction in mIPSC amplitude within 20 min of recording ( Figure 1F : SUK4, 36.2% ± 3% reduction in mean mIPSC amplitude n = 7, p < 0.05), as can clearly be seen in representative mIPSC traces ( Figure 1C ) and by a leftward shift to smaller amplitudes in cumulative probability plots ( Figure 1A ). In contrast there was no significant decrease in mean mIPSC amplitude in control 9E10 dialyzed neurons (Figures 1D and 1F: 9E10, 5 .6% ± 1.7% reduction, n = 5). Neither SUK4 nor 9E10 antibody was found to affect mIPSC interval (Figures 1B, 1E, and 1F: SUK4, 8 .2% ± 4.4% reduction in mean mIPSC interval; 9E10, 5.3% ± 1.6% reduction). Dialysis of SUK4 antibody did not affect mIPSC kinetics, implying that (A-F) mIPSCs in neurons dialyzed with either SUK4 or control 9E10 antibodies. Cumulative distribution plots show mIPSC amplitudes shifted leftward in SUK4-dialyzed (A) but not control 9E10 dialyzed (D) neurons at t = 20 compared with t = 0 min. There is no change in mIPSC interval for either SUK4 or 9E10 (B and E). Representative traces reveal time-dependent reduction in mIPSC sizes upon dialysis of SUK4, but not control 9E10 antibody (C). Summary bar graphs (F) show the percentage (mean and standard error of the mean [±SEM]) reduction of mIPSC amplitude and interval produced by SUK4 or 9E10 after 20 min of antibody dialysis (SUK4, n = 7; 9E10, n = 5; *p < 0.05). (G and H) Immunofluorescence and CLSM reveals that SUK4 treatment of neurons reduces synaptic GABA A R cluster area (arrowheads) compared with 9E10 control (scale bar = 5 mm). Error bars, SEM; n = 3 experiments, 15 neurons; **p < 0.01 (Student's t test). (I-K) Evoked whole-cell recordings of GABA A R currents (I) and NMDAR currents (J) were recorded from neurons dialyzed with either the SUK4 or boiled (inactive) antibody control. SUK4 antibody caused a gradual reduction of GABA A R currents, but the boiled antibody control had no effect. Dialysis of either antibody failed to effect NMDAR currents. (K) Summary bar graph showing the percentage reduction in ionic currents. Error bars, SEM; n = 6-7; *p < 0.05. KIF5 does not selectively transport GABA A Rs with particular kinetics (see Table S1 available online). Similar results were also seen with SUK4 and 9E10 FAb fragments (Figures S1A-S1E). Thus, our results support a key role for KIF5 function in maintaining inhibitory synaptic transmission.
We hypothesized that the effect of SUK4 on inhibitory transmission was mediated by blocking KIF5-dependent GABA A R delivery to synapses. To test this, SUK4 or control 9E10 antibody was introduced into cultured neurons by complexing with a membrane permeant carrier peptide (Coulpier et al., 2002; Morris et al., 2001 ) and the effect on surface GABA A R cluster area was determined using immunofluorescence and confocal laser scanning microscopy (CLSM). Cell surface synaptic GABA A R clusters were identified with an antibody to the extracellular domain of the GABA A R g2 subunit, while antibodies to the vesicular inhibitory amino acid transporter (VIAAT; a marker of inhibitory presynaptic terminals [Dumoulin et al., 1999] ) were used to identify inhibitory synapses on neuronal dendrites. A mouse secondary antibody verified that SUK4 penetrated the neurons (Figure S1G ). Neurons treated with SUK4 showed a significant decrease in GABA A R cluster area in dendrites compared with control mock-treated or 9E10 treated neurons (Figures 1G and 1H ; SUK4 treatment reduced GABA A R cluster area by 46.5% ± 11.9% compared with 9E10 controls, n = 5, p < 0.01), but with no change in the ratio of synaptic to nonsynaptic GABA A R clusters ( Figure S1F ), strongly suggesting that blocking KIF5 activity decreases the delivery of GABA A Rs to synapses.
We also compared the effect of blocking KIF5 activity on GABA A R responses with its effect on NMDA receptor (NMDAR) mediated responses, which are trafficked by a different KIF, the motor protein KIF17 (Guillaud et al., 2003; Setou et al., 2000) . Compared with control inactive (boiled) SUK4 antibody ( Figures 1I and 1K ), SUK4 dialysis rapidly and dramatically reduced GABA A R mediated whole-cell responses in recorded neurons (Figures 1I and 1K: 35 .1% ± 7.9% reduction in GABA response within 20 min with SUK4, n = 6, p < 0.05, compared with 8.7% ± 2.2% reduction for inactive boiled SUK4, n = 7), (I-N) Coprecipitation and pull-down assays of GABA A Rs, KIF5 and HAP1 from rat brain reveals they form complexes in vivo (WB = western blot; input = 5%-15% of the brain lysate present in the assay; each blot represents at least three repetitions). Western blots of pull downs with GST fusion proteins of the intracellular loops of GABA A R subunits b1, 2, and 3 show they were able to bring down kinesin heavy chains (I) as was immunoprecipitation with antibodies against the b3 subunits of GABA A Rs (J). HAP1 antibodies also immunoprecipitate KIF5 when western blots are probed with a pan KIF5 antibody (K) or with specific antibodies against both KIF5B (L) and KIF5C (M). In reverse immunoprecipitation experiments with anti-GABA A R b3 antibodies and anti-KIF5C, HAP1a and HAP1b are present in immune pellets (N).
(O and P) The kinesin motor subunits KIF5A-C and kinesin light chain (KLC) were translated in vitro and labeled with [
35 S]-methionine. The resulting protein was subjected to pull-down assay with GST-HAP1, and GST alone as control, separated by SDS-PAGE (O) and radioactivity detected using a phosphor storage screen. (P) Summary bar graph of relative binding of KIF5 subunits to HAP1. Error bars, SEM; n = 5; *p < 0.05, Student's t test.
whereas neither active nor inactive SUK4 affected NMDAR-mediated responses (Figures 1J and 1K: SUK4: 9.4% ± 1.8% reduction in NMDA response, n = 7; boiled SUK4: 8.1% ± 1.7%, n = 7), further supporting the specificity of KIF5 for selectively trafficking GABA A Rs to synapses.
HAP1 Is the Adaptor Linking KIF5 to GABA A Rs If KIF5 is important for synaptic delivery of GABA A Rs, then we would expect to detect localization of KIF5 and GABA A Rs to the same neuronal compartments. In agreement with this, immunofluorescence and CLSM with antibodies to the GABA A R g2 subunit and antibodies specific to KIF5B (Figure 2A ) or KIF5C ( Figure 2B ), revealed that a proportion of KIF5 staining colocalized with GABA A R clusters in the neuronal somata and dendrites of cultured hippocampal and cortical neurons (see also Figure S2 for whole images of hippocampal neurons and for labeling of cortical neurons). Furthermore, electron microscopy of in vivo hippocampus and rat ventral spinal cord, revealed that KIF5-positive deposits were consistently found in the vicinity of postsynaptic membranes and decorating the postsynaptic side of symmetrical type 2 contacts, defined as inhibitory by the pleomorphic nature of the vesicles within the presynaptic boutons and by their narrow (15-20 nm) synaptic cleft ( Figures 2C-2H ). With pre-embedding immunolabeling and gold-toned silver intensified nanogold particles, KIF5 staining was found associated with small subsynaptic intracellular cisternae, which were often located below or at the edge of postsynaptic differentiations that may be part of subsynaptic tubulovesicular endosomes ( Figures 2C and 2E ). Double detection of GAD and KIF5, with immunoperoxidase and gold toned silver-intensified nanoparticles, respectively, confirmed the inhibitory nature of the presynaptic terminals (Figures 2G and 2H) .
We would also expect to detect protein complexes of KIF5 and GABA A Rs in vivo. To investigate this we carried out glutathione-S-transferase (GST) pull downs and coimmunoprecipitation assays from rat brain lysate. GST-fusion proteins of the GABA A R b1-3 subunit intracellular domains ( Figure 2I ), or rat brain immunoprecipitated GABA A Rs ( Figure 2J ) could readily coprecipitate KIF5 heavy chains, providing evidence that KIF5 motor proteins form complexes with GABA A Rs in vivo. Motor proteins often determine cargo selectivity by linking to the cargo via an adaptor protein (Hirokawa and Takemura, 2005) . HAP1 is involved in motor-protein-dependent transport of neuronal cargo, associating with motor protein complexes (Engelender et al., 1997; Gauthier et al., 2004; Li et al., 1998; McGuire et al., 2006) , as well as interacting directly with GABA A Rs (Kittler et al., 2004) , and therefore was a good candidate adaptor to link GABA A R transport vesicles with KIF5 motors. HAP1 immunoprecipitated from solubilized brain extracts readily coprecipitated KIF5, as demonstrated with either a pan anti-KIF5 antibody (which recognizes all three KIF5 heavy chains, Figure 2K ) or using anti-KIF5B and anti-KIF5C-specific antibodies (Figures 2L and 2M, respectively) . In the reverse experiment, HAP1 readily coprecipitated with immunoprecipitated KIF5C or GABA A R b3 subunits, further confirming that in vivo GABA A Rs are found in complexes with HAP1 and KIF5 ( Figure 2N ). To test if the interaction between HAP1 and KIF5A-C heavy chains was direct, we performed GST fusion protein affinity purification experiments with GST-HAP1 and individual 35 S-methionelabeled KIF5A-C heavy chains or the kinesin light chain (KLC), which confirmed a direct interaction of KIF5 heavy chains with HAP1 (highest for KIF5B and KIF5C isoforms; Figures 2O and 2P). Thus HAP1 is the adaptor linking KIF5 to GABA A Rs.
KIF5 Mediates Insertion of GABA A Rs into the Surface Membrane at Synapses
To further investigate the mechanism of KIF5-dependent GABA A R trafficking we identified the molecular determinants of the HAP1-KIF5 interaction. KIF5 heavy chains comprise an N-terminal motor domain and a C-terminal nonmotor domain. Initial experiments, using coimmunoprecipitation and coexpression of epitope tagged KIF5C N-terminal motor domain or C-terminal nonmotor domain proteins, revealed that HAP1 interacts with the KIF5C nonmotor domain ( Figure S3 ), which comprises the stalk domain, the kinesin light chain binding domain, and the cargo binding domain. Using additional GFP tagged constructs for KIF5B (or KIF5C; not shown), lacking either the stalk domain or both the stalk and light chain binding regions, we determined that the C-terminal cargo binding domain of KIF5 is the minimal region sufficient for mediating an interaction with HAP1, as shown by the fact that GST-HAP1 ( Figure S3D ) or GST-HAP1 fragments ( Figures 3A-3C ) could readily pull down the C-terminal domain of KIF5B (residues 814-963, from here on called the HAP1-binding domain, or HBD; see Figure 3A ). In complementary GST pull-down experiments with GST-HAP1 deletion constructs ( Figures 3A-3C ), we also determined that a region containing coiled-coil domains 1 and 2 (part of the HAP N-terminal homology domain) was sufficient for interacting with the C-terminal region of the KIF5 motor ( Figures 3B and 3C ). We used the HAP1 binding domain of KIF5 (KIF5-HBD) as a dominant negative construct to further investigate the consequences of disrupting KIF5-dependent GABA A R trafficking to synapses. Using surface biotinylation to quantify surface GABA A R levels, we found that, compared with control GFPtransfected neurons, neurons expressing the GFP KIF5B-HBD produced a significant decrease in the cell surface number of GABA A Rs containing b3 subunits (68.5% ± 6.0% of control, n = 8, p < 0.005, Figures 3D-3F ), whereas surface levels of either the transferrin receptor (TfR) or the NMDAR were unaffected ( Figures S3E and S3F ). The source of GABA A Rs from the internal pool that supplies fast synaptic receptor insertion remains unknown. However, GABA A Rs have been previously demonstrated to be rapidly reinserted into the membrane from an intracellular pool of internalized receptors (Kittler et al., 2004) . After labeling this intracellular pool of GABA A Rs with biotin, the loss of biotinylated internal GABA A Rs after a second biotin cleavage (see Experimental Procedures) provides a measure of receptor insertion rate into the membrane (Ehlers, 2000; Kittler et al., 2004) . Internal biotinylated GABA A Rs remaining during the time course were then compared with those at the start of the reinsertion time course (i.e., time 0 in Figure 3G ), designated as 100%. We found that expressing GFP KIF5B-HBD in neurons resulted in a significant reduction in the loss of the internal biotinylated receptor pool (i.e., more internal biotinylated receptors remained) compared with GFP controls. This gives a significant decrease in GABA A R insertion levels at 30 and 60 min upon disruption of HAP1/KIF5-dependent trafficking (Figures 3G and 3H: at 30 min 38.6% ± 2.4% receptors remained in the internal pool for GFP KIF5B-HBD transfected neurons compared with 27.1% ± 3.9% receptors remaining in the internal pool for GFP control transfected neurons; at 60 min 25.1% ± 2.1% for GFP KIF5B-HBD compared with 14.2% ± 2.9% for GFP control; n = 5, p < 0.05). In contrast GABA A R endocytosis was not affected by expressing GFP KIF5B-HBD ( Figures S3G, S3H ). Our results demonstrate that disrupting KIF5-dependent trafficking by expressing GFP KIF5B-HBD decreases receptor insertion into the surface membrane. Functional confirmation that this decrease in trafficking resulted in a loss of synaptic receptors was observed from whole-cell patch-clamp recordings ( Figures 4A-4E ). Neurons transfected with GFP KIF5B-HBD showed a significant decrease in mIPSC amplitudes compared with GFP-transfected neurons, ( Figures 4A, 4C , and 4D; mean mIPSC amplitude in GFP KIF5B-HBD transfected neurons 17.8 ± 2.4 pA, n = 6, compared with 27.8 ± 3.7 pA, n = 5, for control GFP transfected neurons, p < 0.05), which was also indicated by a leftward shift toward lower amplitudes in the cumulative distribution plots ( Figure 4A ). An even greater reduction was seen upon neuronal expression of To further support the role of the HAP1/KIF5 complex for trafficking GABA A Rs to synapses, we also investigated the functional consequences of expressing in neurons the domain on HAP1 to which KIF5 binds (i.e., the HAP1-KIF5 binding domain; HAP1-KBD; Figure 3B ). Compared with neurons expressing GFP, neurons expressing GFP HAP1-KBD showed reduced mIPSC amplitudes, (Figures 4H, 4J, and 4K; mIPSC amplitude in GFP-expressing neurons: 37.1 ± 2.4 pA, n = 8, and 22.9 ± 2.1 pA in GFP HAP-KBD-expressing neurons, n = 7, p < 0.01), while similar to expression of KIF5-HBD, mIPSC frequency remained unaffected ( Figures 4I, 4J , and 4L; GFP: 5.1 ± 0.7 Hz, n = 8; HAP1-KBD: 4.4 ± 0.4 Hz, n = 7). In contrast to the effects observed on GABA A R mIPSC amplitude upon expression of KIF5-HBD or HAP1-KBD, targeting the function of the NMDAR motor KIF17, which does not interact with HAP1 ( Figure S4L ) and which blocks trafficking of NMDARs (Guillaud et al., 2003) , had no effect on inhibitory synaptic function ( Figures S4G-S4K ).
These results further support a critical role for the HAP1/KIF5 complex in trafficking GABA A Rs to synapses. Our results suggest that HAP1 is a specificity adaptor for the recruitment of GABA A R containing transport vesicles to a KIF5 transport pathway for their rapid delivery to synapses. To further validate the role of the HAP1-KIF5 complex, we used RNA interference (RNAi) to knock down HAP1 expression ( Figures 5A-5C ) and determined the effect on trafficking and synaptic inhibition. Similar to the effect of disrupting KIF5 function (by expressing KIF5-HBD), biotinylation experiments revealed that knocking down HAP1 (Figures 5A-5C ) resulted in a substantial decrease in the number of surface GABA A Rs (for HAP1 RNAi-expressing neurons surface levels were 43.1% ± 8.2% of control scrambled RNAi expressing neurons, n = 6, p < 0.0005, Figures 5D and 5E ) without affecting the surface levels of TfR or the NMDAR (Figures S5A and  S5B) . Biotinylation experiments also revealed that HAP1 knockdown resulted in a significant reduction in rates of GABA A R insertion into the membrane at 30 and 60 min compared with RNAi control transfected cells (Figures 5F and 5G) . At 30 min the control RNAi cells had 25.3% ± 2.6% of receptors remaining in the internal pool compared with 40.7% ± 5.5% receptors remaining for HAP1 RNAi, while at 60 min the control RNAi cells had 13.0% ± 2.2% receptors remaining in the internal pool compared with 25.2% ± 5.6% in HAP1 RNAiexpressing cells; n = 7-9; p < 0.05), but HAP1 RNAi did not alter GABA A R endocytosis ( Figures S5C and S5D ). In agreement with these observations, patch-clamp recordings of neurons expressing the HAP1 RNAi revealed that mIPSC amplitude, but not frequency, in neurons was dramatically reduced compared with the scrambled control RNAi (Figures 6A-6E: HAP1 RNAi mIPSC amplitude, 23.7 ± 2.1 pA, n = 8 compared with control RNAi mIPSC amplitude 41.6 ± 2.3 pA, n = 7, p < 0.05; HAP1 RNAi mIPSC frequency, 4.2 ± 0.17 Hz, n = 8 compared with control RNAi mIPSC frequency 4.2 ± 0.25 Hz, n = 7). This correlates with the reduced size of synaptic GABA A R clusters as determined by immunofluorescence and confocal imaging (70.4% ± 8.3% of control, n = 3, p < 0.05, see Figures 6F and 6G ), while no effect on the synaptic to nonsynaptic ratio of GABA A R cluster numbers was observed ( Figure S6A ).
To further study the role of HAP1-dependent GABA A R trafficking, we also performed live cell imaging experiments in neurons expressing GFP-labeled GABA A R transport vesicles. We designed a new HAP1 (or control) shRNAi vector coexpressing GFP tagged g2 GABA A R subunits (g2 GFP ) such that neurons expressing GFP labeled GABA A Rs would also express either HAP1 RNAi or control RNAi (Figures S6B-S6E) . By imaging over time, motile g2 GFP labeled GABA A R transport vesicles in dendrites were visualized using kymographs ( Figures 6I-6J 0 ) that were created by projecting sequential line scans through a process of interest onto the y axis (Macaskill et al., 2009 GFP -GABA A R vesicles moving far shorter distances in the HAP1 RNAiexpressing neurons than in control cells ( Figure 6H ; average track run length in control RNAi cells 32.9 ± 3.1mm, and in HAP1 RNAi cells 23.6 ± 2.9 mm, p < 0.05, n = 45 tracks in each case).
Mutant PolyQ Huntingtin Disrupts GABA A R Trafficking, Synaptic Receptor Delivery, and Inhibitory Transmission HAP1 function is disrupted by the mutant (polyQ) version of huntingtin that causes Huntington's disease (Gauthier et al., 2004; Li et al., 1995) . HAP1-KIF5-dependent GABA A R trafficking is therefore a likely target for disruption in HD, which would lead to pathological alterations in inhibition. To further investigate this possibility, we performed live cell imaging experiments in neuronal cells derived from knock-in mice, where a CAG expansion (encoding poly-glutamines) has been inserted into the endogenous mouse htt gene (Trettel et al., 2000) . These cell lines reflect the closest situation to HD patients, because wild-type or polyQ-htt is expressed at endogenous levels. Neuronal cells containing either two copies of wild-type htt (wild-type neuronal cells, +/+), or two copies of mutant htt (homozygous mutant neuronal cells, 109Q/109Q) were transfected with GFP tagged GABA A Rs (a1b3g2 GFP ) and imaged using live cell video microscopy to monitor the trafficking dynamics of GFP GABA A R transport vesicles ( Figures 7A-7C and Movies S1 and S2). By tracking GFP GABA A R transport vesicles, the influence of wild-type (WT) or polyQ-htt on vesicle velocity and vesicle run length was determined. These experiments revealed a significant decrease in the velocity ( Figures 7A and 7C , 109Q/109Q cells, 0.36 ± 0.01 mm/s compared with +/+ controls, 0.41 ± 0.01 mm/s, p < 0.05) and run length ( Figures 7B and 7C , 109Q/109Q cells, 5.4 ± 0.6 mm compared with +/+ cells, 7.6 ± 0.6 mm, p < 0.05) of transport vesicle dynamics were occluded by coexpression of KIF5-HBD, which reduced GABA A R vesicle trafficking to the same level in both +/+ and 109Q/109Q cells ( Figure S7 ). Our results strongly suggest that mutant polyQ-htt causes decreased accumulation of GABA A Rs at inhibitory synapses (leading to compromised inhibition) by reducing the processivity (Gauthier et al., 2004) and trafficking ability of HAP1-KIF5-dependent GABA A R transport vesicles for receptor delivery to inhibitory synapses. To address the functional consequences of altered HAP1-KIF5-dependent GABA A R trafficking by polyQ-htt on inhibitory polyQ-htt: 13.7 ± 1.4 pA, n = 6, p < 0.05), which was also indicated by a leftward shift toward lower amplitudes in the cumulative distribution plot ( Figure 7D ). Although polyQ-htt caused a significant reduction in mIPSC amplitude ( Figure 7H , 59.7% ± 4.1%, p < 0.05), it had little effect on mIPSC frequency ( Figures 7E, 7F , and 7H). Expressing GFP polyQ-htt also resulted in a significant decrease in the area of GABA A R clusters in neuronal dendrites compared with control GFP WThtt-transfected cells (41.5% ± 11.5% of control, n = 5, p < 0.01, Figure 7I , 7J), but not the ratio of synaptic to nonsynaptic GABA A R clusters at the cell surface ( Figure S7F) . These results clearly demonstrate that mutant polyQ-htt disrupts delivery of GABA A R to synapses, leading to compromised inhibitory synaptic transmission.
DISCUSSION
We have analyzed the mechanisms that regulate the rapid transport of GABA A Rs to synapses. We demonstrate that delivery of GABA A Rs from internal compartments to surface and synaptic sites is dependent on a HAP1-KIF5 motor protein complex. Electrophysiological recordings in the present study provide evidence that KIF5-dependent trafficking of GABA A Rs to synapses is a critical regulator of rapid synaptic GABA A R delivery and of the strength of the inhibitory synapses. This mechanism is likely to be a locus for regulation of trafficking of GABA A Rs during inhibitory synaptic plasticity and homeostasis.
In agreement with an important role for KIF5 and HAP1 in regulating GABA A R transport, we find that GABA A Rs, KIF5 and HAP1 interact in vivo and that KIF5 is localized at inhibitory postsynaptic domains (Figure 2) . Furthermore, using protein interaction mapping experiments, we reveal that KIF5 heavy chains interact directly with HAP1 via a C-terminal domain in KIF5 and the central HAP1-N-terminal homology domain rich in coiled coils (Figure 3 ). An earlier report demonstrated a direct interaction between a C-terminal region of HAP1 and the KLC (McGuire et al., 2006) . However, we observed a much weaker direct interaction of the KLC with HAP1 compared with KIF5B and KIF5C in our pull-down assay, and we find the KLC binding domain of KIF5 is not necessary for the direct high-affinity interaction between KIF5 heavy chains and HAP1 (Figure 2) . Thus, HAP1 acts as the adaptor protein directly linking GABA A R transport vesicles to KIF5 heavy chains for their trafficking along microtubules. Further work is needed to determine if KLC plays an additional regulatory role in the GABA A R-HAP1-KIF5 complex. There are a large number of KIF motors (Miki et al., 2001 ), and we cannot discount the possibility that other KIFs could interact with HAP1 and contribute to GABA A R trafficking. However, we show here for at least one other KIF isoform (KIF17) that a direct interaction with HAP1 was not detected, and moreover that KIF17 activity does not contribute to inhibitory synapse function, supporting the specificity of the KIF5 interaction with HAP1 and its role in GABA A R trafficking.
To test the functional significance of HAP1/KIF5-dependent GABA A R trafficking in regulating surface and synaptic GABA A R number, we examined the consequences for inhibitory synaptic currents of directly blocking KIF5 function or inhibiting the HAP1-KIF5 linkage to GABA A Rs. Acutely dialyzing KIF5 function blocking antibody via the electrophysiological recording pipette resulted in a rapid decrease in mIPSC amplitude, demonstrating a crucial role of KIF5 motor proteins in delivering GABA A Rs to synapses on rapid timescales (Figure 1 ). Transducing neurons with the same antibody also reduced GABA A R cluster area, as determined by immunofluorescence and CLSM. Transfection of neurons with the HAP1 binding domain of KIF5 to compete with HAP1 for binding to KIF5, or using RNAi to knock down HAP1 and decrease the amount of HAP1-KIF5 complex present, significantly decreased surface GABA A R number, insertion of GABA A Rs into the membrane from the internal pool, GABA A R cluster area, and the amplitude of mIPSCs (Figures 3-6) . Expressing the KIF5 binding domain of HAP1 also significantly reduced the amplitude of mIPSCs. Moreover, knockdown of HAP1 also substantially reduced the number and run length of GABA A R transport vesicles. Our observed 35%-45% reduction of mIPSC size presumably reflects an action on the actively trafficked pool of receptors, which is in agreement with the observed effects on receptor trafficking and receptor insertion into the membrane. In contrast, disrupting KIF5-dependent trafficking did not alter surface TfR or NMDAR levels or the size of NMDAR responses, and blocking the function of the KIF17 motor for NMDARs did not effect GABAergic mIPSCs. Thus, the number of surface and synaptic GABA A Rs can be specifically controlled by the extent of HAP1-KIF5-dependent membrane insertion of GABA A Rs from the internal receptor pool to the postsynaptic membrane. In addition to being a potential locus for regulation of GABA A R trafficking during inhibitory synaptic plasticity and homeostasis, HAP1/KIF5-dependent GABA A R trafficking during the embryonic and early postnatal period, when GABA A Rs can be excitatory (Ben-Ari et al., 2007) , may also be important for inhibitory synapse and circuit development.
Changes in the trafficking of GABA A Rs to and from the postsynaptic membrane are likely to underlie plasticity of GABAergic synapses in pathological conditions such as stroke and epilepsy, leading to alterations in inhibition and neuronal excitability (Mielke and Wang, 2005; Naylor et al., 2005) . HAP1 interacts with huntingtin, the protein product mutated (by an expanded polyQ tract) in HD. HAP1-dependent motor protein trafficking of vesicles is modified by mutant polyQ-htt and may underlie cell death in HD (Gauthier et al., 2004) . Our data suggest that HAP1-KIF5-dependent GABA A R transport is disrupted by mutant polyQ-htt in HD. PolyQ-htt slowed the GABA A R vesicle transport speed, resulting in a reduced delivery and number of GABA A Rs at inhibitory synapses, and a reduced inhibitory synaptic response (Figure 7) . HAP1 interacts more tightly with polyQ-htt compared with WT huntingtin (Li et al., 1995) . Wildtype huntingtin, via an interaction with HAP1, may be an integral component of the HAP1-KIF5 complex and traffic with GABA A R vesicles. In HD pathology, polyQ-htt may remain associated with GABA A R transport vesicles, but alter the function of the HAP1-KIF5 complex to disrupt the efficiency of GABA A R vesicle trafficking. Alternatively, mutant polyQ-htt may disrupt the trafficking by sequestering HAP1 and KIF5 motors away from GABA A R transport vesicles. Further work will be needed to determine which mechanism results in mutant polyQ-htt disrupting HAP1-KIF5 dependent GABA A R trafficking.
Altered KIF5 motor-protein-dependent GABA A R trafficking may directly contribute to reduced synaptic inhibition and altered information processing in HD. PolyQ-htt-dependent enhancement in NMDA receptor function and trafficking are proposed to exacerbate excitotoxicity in HD Zeron et al., 2002) . Furthermore, increased neurotransmission and neuronal excitability are also proposed to contribute to the neuronal degeneration caused by full-length polyQ-htt early in pathology (Romero et al., 2008) and early deficits in cortical inhibition have also been reported . Whether polyQ-htt could also influence GABA A R trafficking, synapse development, and inhibitory network function early during the development of GABAergic pathways is an interesting possibility and it is intriguing to note that in infants with early onset HD, the symptoms often include epileptic seizures (Harper, 2002) . At later stages, disrupted GABA A R trafficking to synapses and compromised inhibition caused by mutant htt is likely to also inhibit a homeostatic response to potentiated excitatory synaptic activity and neuronal excitability in HD, and thus significantly contribute to pathological ''anti-homeostasis,'' leading to further disruption of the excitatory/inhibitory balance and increased neuronal excitotoxicity. This raises the possibility of a new therapeutic target in HD: blocking recruitment of polyQhtt to HAP1, so that disruption of KIF5-dependent trafficking of GABA A Rs to synapses is prevented.
EXPERIMENTAL PROCEDURES
Details regarding antibodies, immunofluorescence staining and analysis, molecular biology, and plasmid constructs are included in the Supplemental Experimental Procedures.
Electron Microscopy
Adult Sprague-Dawley rats were anesthetized with pentobarbital (60 mg/kg) and intracardially perfused with 4% paraformaldehyde (PFA) and 0.1% glutaraldehyde in phosphate-buffered saline (PBS). After dissection, the cervical spinal cord and hippocampal tissue were kept overnight at 4 C in 4% PFA.
Vibratome sections (100 mm) were cryoprotected for 3 hr in 20% glycerol and 20% sucrose at room temperature. They were then permeabilized by freezethawing, extensively rinsed in PBS, and immersed for 20 min in 50 mM ammonium chloride and for 30 min in PBS with 0.1% gelatin (PBSg). For immunogold detection of KIF5, vibratome sections were incubated for 12 hr (4 C) in the anti-KIF5 antibody and antibody binding sites detected using secondary nanogoldcoupled antibody (1% in PBSg, Nanoprobe, Stony Brook, NY). Gold particles were intensified with HQ silver kit (Nanoprobe) and subsequently gold-toned (Gardiol et al., 1999) . Immunoperoxidase methods (Colin et al., 1998) were used for the detection of GAD and KIF5C. For double detection of KIF5 and GAD (Figures 2e and 2f ) the KIF5 detection procedure was performed first. After gold toning, the sections were subsequently kept overnight (4 C) in anti-GAD before immunoperoxidase detection. After dehydration and osmification, the sections were flat-embedded. Observations of ultrathin sections (pale yellow) were contrasted with uranyl acetate and Reynolds lead citrate (Poole, UK). Images were collected with a JEOL 100CXII electron microscope (Paris, France).
Immunoprecipitation Assays from Rat Brain Homogenates
Adult rat brains were homogenized on ice in 10 ml buffer (50 mM HEPES [pH 7.5], 0.5% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF in the presence of antipain, pepstatin, and leupeptin) then left to rotate at 4 C for 2 hr. Membranes were pelleted by ultracentrifugation at $66,000 g for 40 min at 4 C. Protein content of the supernatant was assayed by Bio-Rad protein assay. Then 2-5 mg protein was transferred to a 1.5 ml microcentrifuge tube and made up to 500 ml with homogenization buffer. For coimmunoprecipitations 1-2 mg primary antibody was added in parallel to a suitable nonimmune IgG control antibody (Santa Cruz Biotechnology) of the same species. Samples were incubated overnight at 4 C with rotation. Complexes were precipitated with 15 ml of 50% protein A (for rabbit antibodies) or protein G (for goat antibodies) sepharose bead slurry (Generon) for 1 hr at 4 C. Beads were then washed three times by centrifugation and resuspension in 1ml homogenization buffer. Samples were suspended in 3X protein sample buffer and analyzed by SDS-PAGE and western blotting.
Pull-Down Assays
Affinity purifications, using GST-fusion proteins purified from E. coli, were performed as described in a number of previous studies (Kittler et al., 2005 (Kittler et al., , 2000a . For pull downs from rat brain, 50 mg GST fusion protein immobilized on agarose beads was incubated in rat brain homogenate for 2 hr at 4 C, followed by five washes in homogenization buffer. Complexes were washed five times with pull-down buffer and then analyzed by SDS-PAGE and western blotting. For pull downs from transfected COS cells, transfected cells were harvested 24 hr posttransfection. Then 10 cm dishes of COS cells were solubilized in 0.5 ml pull-down buffer (50 mM HEPES [pH 7.5], 0.5% Triton, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF in the presence of antipain, pepstatin, and leupeptin) for 45 min at 4 C. Detergent solubilized extracts were collected following centrifugation for 10 min at 17,900 g, 4 C, placed in a fresh 1.5 ml microcentrifuge tube, and incubated with 20 mg of GST fusion protein for 2 hr. Complexes were washed five times with pull-down buffer and then analyzed by SDS-PAGE and western blotting with mouse anti-GFP (Roche). For pull downs with radiolabeled protein, KIF5A, KIF5B, KIF5C, and KLC1 were in vitro translated (IVT) from their appropriate pRK5 vectors using TNT SP6 Quick coupled Transcription/Translation system (Promega) and labeled with [
35 S]-methionine (Perkin Elmer) following the manufacturer's instructions, with a 50 ml final volume. Then 10-15 ml IVT S 35 labeled protein was incubated for 2 hr with 10 mg GST fusion protein immobilized on glutathione agarose beads in a final volume of 500 ml, diluted in pull-down buffer. Complexes were washed three times in pull-down buffer and resolved by SDS-PAGE. Gels were dried and radioactivity detected using a storage phosphor screen.
Cell Culture, Transfection and Transduction COS and HEK cells were maintained as described previously and transfected using electroporation (Kittler et al., 2000a (Kittler et al., , 2000b . The neuronal cells (109Q/ 109Q and +/+) derived from knockin mice (Trettel et al., 2000) were cultured in DMEM supplemented with 10% FBS, PenStrep, 40 mg/ml G418, 1% glutamine and sodium pyruvate. Cortical, hippocampal, and striatal cultures were isolated from E18 or P0 Sprague-Dawley rats as described in a number of previous publications (Banker and Goslin, 1998; Chen et al., 2006; Kittler et al., 2004; Macaskill et al., 2009) . Cultures for biotinylation experiments were transfected using Amaxa nucleofector technology using program O-003 and plated onto poly-L-lysine prepared 10 cm dishes. +/+ and 109Q/109Q cultures for live video microscopy were transfected using Amaxa nucleofector technology using program T27 and plated onto coverslips for imaging. Striatal cultures for surface labeling and analysis of GABA A R clusters were transfected by a calcium phosphate method as previously described at 7-10 days in vitro (DIV) and allowed to express for at least 3 days before fixation. Monoclonal antibodies (affinity purified SUK4, or 9E10 antibody as a control) were transduced across the plasma membrane of DIV 10-14 neurons using Chariot reagent (Active Motif) following the manufacturer's instructions with minor modifications (Coulpier et al., 2002; Kittler et al., 2006; Ma et al., 2006) . In brief, per well of a 24 well plate, 2 ml Chariot reagent was diluted in 50 ml water before precomplexing with 20 mg antibody in 50 ml PBS for 30 min. The 100 ml of complexed antibody/chariot was then overlaid onto the cultured neurons with 100 ml fresh complete neuronal culture medium and left to incubate at 37 C for 1 hr. Another 400 ml of fresh medium was then overlaid on the neurons and incubation was continued for 12 hr before cells were fixed and stained (see Supplemental Experimental Procedures). 
Video Microscopy

Surface Biotinylation Assay
Nucleofected cultured cortical cultures were kept at 4 C and rinsed with PBS (all washing steps were performed in PBS supplemented with 1 mM CaCl 2 and 0.5 mM MgCl 2 ) before incubation with 0.5 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Pierce) for 12 min. The surface biotinylation reaction was quenched using three washes of 1 mg/ml BSA in Mg 2+ /Ca 2+ supplemented PBS. Cells were washed and solubilized in 360 ml RIPA buffer (50 mM Tris [pH 7.5], 1 mM EDTA, 2 mM EGTA, 150 mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, 1 mM PMSF with antipain, pepstatin, and leupeptin) for 1 hr at 4 C. Cell membranes were pelleted at 14,000 rpm for 10 min at 4 C. Then 60 ml (20%) was kept to analyze as an input. The remainder was incubated with 50 ml UltraLink NeutrAvidin bead slurry (Pierce) for 2 hr at 4 C. Beads were washed twice with highsalt (0.5 M NaCl) RIPA buffer and once with normal (0.15 M NaCl) RIPA buffer.
Complexes were separated by SDS-PAGE and analyzed by western blotting. GABA A Rs were detected with rabbit anti-GABA A R-b3 subunit as primary antibody and [125I]-labeled donkey anti-rabbit (Perkin Elmer) as secondary antibody. Radioactivity of western blots was detected using a storage phosphor screen. For biotin endocytosis assays, nucleofected cortical cultures were surface biotinylated as above and following quenching, media was returned to the dishes and neurons were incubated at 37 C for 30 min to allow internalization.
Cleavage of remaining surface biotin was carried out at 4 C by two 15 min incubations in cleavage solution (50 mM glutathione, 10 mM EDTA, 75 mM NaCl, 1% BSA [pH 7.8]). Cultures were solubilized and complexes precipitated as for surface biotinylations. Reinsertion biotinylation assays of cortical cultures were performed as described previously (Kittler et al., 2004) . Briefly, cortical neurons were labeled with biotin and receptors were allowed to internalize for 30 min (the period for maximal receptor internalization [Kittler et al., 2004] ), before cleavage with glutathione. Neurons were then incubated at 37 C for further time periods with glutathione in the external culture medium to cleave any internalized biotinylated receptors recycling to the cell surface. The loss of biotinylated internalized GABA A Rs after the second biotin cleavage provides a measure of receptor recycling (Ehlers, 2000) . Internal b3-subunit levels remaining were then compared with those at the start of the second incubation period with glutathione, designated as 100%.
Whole-Cell Recordings
Whole-cell recordings of mIPSCs from cultured neurons were performed using standard voltage-clamp techniques (Chen et al., 2006; Kittler et al., 2004) . Electrodes were filled with the following internal solution: 100 mM CsCl, 30 mM N-methyl-D-glucamine, 10 mM HEPES, 1 mM MgCl 2 , 1 mM EGTA, 5 mM QX314, 12 mM phosphocreatine, 5 mM MgATP, 1.5 mM Na 2 GTP, 0.1 mM leupeptin [pH = 7.2-7.3], 265-270 mOsm/l. The neurons were recorded in tetrodotoxin (0.5 mM) and held at À70 mV. Recordings of wholecell ion channel currents used standard voltage-clamp techniques as described previously (Yuen et al., 2008 (Yuen et al., , 2005 . The internal solution contains the following: 180 mM N-methyl-D-glucamine, 40 mM HEPES, 4 mM MgCl 2 , 0.5 mM BAPTA, 12 mM phosphocreatine, 3 mM Na 2 ATP, 0.5 mM Na 2 GTP, and 0.1 mM leupeptin [pH 7.2-7 .3], 265-270 mOsm/l). The external solution consisted of the following: 127 mM NaCl, 20 mM CsCl, 10 mM HEPES, 1 mM CaCl 2 , 5 mM BaCl 2 , 12 mM glucose, 0.001 mM TTX, and 0.02 mM glycine (pH 7.3-7.4, 300-305 mOsm/l). GABA (100 mM) or NMDA (100 mM) was applied for 2 s every 30 s via a gravity-fed ''sewer pipe'' system using capillaries (150 mm inner diameter) positioned a few hundred micrometers from the neuron under study. The membrane holding potential was À40 mV and À70 mV for GABA and NMDA currents, respectively. Data were analyzed with Axograph (Axon Instruments, Union City, CA), Kaleidagraph (Albeck Software, Reading, PA) and Mini Analysis program (Synaptosoft, Leonia, NJ). 
SUPPLEMENTAL INFORMATION
